生物精神病学(Biological Psychiatry)是一本由Elsevier USA出版的一本医学-精神病学学术刊物,主要报道医学-精神病学相关领域研究成果与实践。本刊已入选来源期刊,属于国际一流期刊。该刊创刊于1958年,出版周期Semimonthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为9.6,CiteScore指数18.8,SJR指数3.786。本...
Biological PsychiatryPubMedAJSCIECA中科院1区JCR:Q1 发文量49,248 被引量899,483 影响因子(2023)0.829 AIMS AND SCOPE Biological Psychiatry, founded in 1969, is an official journal of the Society of Biological Psychiatry and the first in the Biological Psychiatry family of journals. Companion titles ...
6.Biological Psychiatry Global Open Science 期刊主页:Biological Psychiatry Global Open Science | Journal | ScienceDirect.com by Elsevier Biological Psychiatry Global Open Science发表新颖的原创研究,这些成果能够展现领域内重要新发现或对该领域的重大影响,包括涉及遗传和环境风险因素、神经回路、神经化学、荷尔蒙功能...
13 November 2023 Read a Q&A with John H. Krystal, MD, Editor-in-Chief of Biological Psychiatry View all news More opportunities to publish your research: Browse open Calls for Papers Special issues and article collections The Biology of Dimensional Psychopathology: Implications for Depression ...
Last update October 2023 Reliability of Neurocognitive Measures for Mental Health Edited by Quentin J.M. Huys Martin Paulus Last update August 2023 Fumbling Toward Equity: Reimagining Biological Psychiatry Through a Lens of Diversity, Equity, and Inclusivity ...
October 2023 Reliability of Neurocognitive Measures for Mental Health Edited byQuentin J.M. Huys,Martin Paulus August 2023 Fumbling Toward Equity: Reimagining Biological Psychiatry Through a Lens of Diversity, Equity, and Inclusivity Edited byKristen L. Eckstrand,Manpreet K. Singh,Olu Ajilore ...
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is an official journal of the Society for Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms, and treatments of disorders of thought, emot...
Understanding the causal impact that clinical risk factors have on healthcare-related costs is critical to evaluate healthcare interventions. Here, we used a genetically-informed design, Mendelian Randomization (MR), to infer the causal impact of 15 risk
Progress in Neuro-Psychopharmacology & Biological Psychiatry Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0278-5846.
C.A.L. is Cofounder, Board Member, and Chief Scientific Officer of Mycobacteria Therapeutics Corporation, and is a member of the faculty of the Integrative Psychiatry Institute, Boulder, Colorado, the Institute for Brain Potential, Los Banos, California, and Intelligent Health Ltd, Reading, UK....